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We read the article entitled ‘‘Don’t forget how severe varicella
can be—complications of varicella in children in a deﬁned Polish
population’’ by Gowin et al.1 with interest. We agree that the
secondary infection of varicella-induced rash is the most common
complication, however once in a while we do see uncommon
complications of this relatively common disease in tropical
countries. The hematologic complications due to varicella are
often underestimated and we would like to describe one such case
seen by us recently.
A 19-year-old unvaccinated woman, with no prior illness, was
referred to our hospital with febrile neutropenia. She had
previously presented to a private clinic with fever of 1-week
duration and pancytopenia. A complete blood count at presenta-
tion to our hospital revealed hemoglobin of 8.6 g/dl, white blood
cells (WBC) of 0.9  109/l, and platelets of 14  109/l. Physical
examination ﬁndings were striking for the presence of a
pleomorphic rash. It was present predominantly over the trunk
and upper limbs and showed hemorrhagic crusting. The rest of the
physical examination was unremarkable. A Tzanck smear from this
rash showed the presence of multinucleated giant cells.
With a clinical diagnosis of varicella, she was started on oral
acyclovir 800 mg ﬁve times a day. The fever subsided in 24 h. From
the third day of therapy, her hemoglobin and WBC and platelet
counts started to improve. After a week of acyclovir therapy, the
vesicular rash had crusted completely. Her complete blood count
at discharge showed a hemoglobin of 9.3 g/dl, WBC count of
7.2  109/l, and platelet count of 180  109/l.
Thrombocytopenia due to viral illness is a well known
phenomenon.2 However, a decrease in all cell lines (pancytopenia)
is a less common presentation. There are a few reports of
pancytopenia associated with varicella zoster virus infection.3–5
The mechanism for the pancytopenia is unclear. Possible
hypotheses proposed are the direct effects of the virus on bone
marrow and the immunological response to the virus.41201-9712/$36.00 – see front matter  2013 International Society for Infectious Disea
http://dx.doi.org/10.1016/j.ijid.2013.06.010Early recognition of the disease and awareness of such
uncommon presentations of varicella are important. This will
avoid the erroneous labeling of a common and easily treatable
disease as a more sinister hematologic disorder.
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